Page 18 - Cell Reports News Today

The Massachusetts Institute of Technology is offering a first-of-its-kind course that trains students to be mediators in conflicts over clean energy projects.

The Massachusetts Institute of Technology is offering a first-of-its-kind course that trains students to be mediators in conflicts over clean energy projects.

The Massachusetts Institute of Technology is offering a first-of-its-kind course that trains students to be mediators in conflicts over clean energy projects.

The Massachusetts Institute of Technology is offering a first-of-its-kind course that trains students to be mediators in conflicts over clean energy projects.

Researchers hope taurine can offer diverse benefits for various long COVID symptoms by affecting multiple body systems.

An experimental vaccine is designed to protect against a variety of deadly coronaviruses.

University of Queensland researchers have shown that endometriosis and irritable bowel syndrome (IBS) share genetic risk factors, explaining why patients with one condition may also have the other.

News and commentary from the world of neurology and neuroscience

The big pharmaceutical companies are creating yet another COVID-19 "vaccine," because apparently, there is no limit to how many times they want the sheep injected. Dr. Kevin Saunders, the associate director of the Duke Human Vaccine Institute, and his team created a trivalent vaccine targeting MERS and two forms of SARS which are all variants of the coronavirus.

The 50 families stretch from the Netherlands and the United Kingdom to the United States and China. Each family has a child who is paralyzed from a mutation in a single gene named Contactin-Associated Protein 1 (Cntnap1).